Key result
Altered platelet subtypes link to disease severity and show potential as novel biomarkers and therapeutic targets.
Why the study?
Current clinical metrics like platelet count and mean platelet volume fail to capture differences in platelet subtypes that contribute to disease pathology, necessitating a more nuanced understanding of platelet heterogeneity.
Design
Review
Authors
Loading...
Supports platelet subtype research as biomarkers; leaves open therapeutic targeting pending prospective validation.
Gautam et al. (2025) studied this question. Alterations in specific platelet subtypes are linked to disease severity, indicating their potential as biomarkers and therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: